14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ABUS vs GMGI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Arbutus Biopharma Corporation (ABUS) is the stronger overall head-to-head candidate over Golden Matrix Group, Inc. (GMGI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABUS carries a Unified Composite Score of 43.4/100 (HOLD) at $4.02 (10.2x Forward P/E, 80.1% operating margin), whereas GMGI carries 51.1/100 (HOLD) at $0.64 (128.2x Forward P/E, -0.8% operating margin).
Composite vs. Pillar Nuance: While GMGI currently prints a higher short-term Unified Composite Score (51.1/100 HOLD vs. ABUS 43.4/100 HOLD), ABUS captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (80.1% vs. -0.8% operating margin) and revenue trajectory (-43.5% vs. +15.4% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABUS vs GMGI. Trailing 12-month operating profitability (ABUS 80.1% vs GMGI -0.8%) and valuation multiples (ABUS 10.2x vs GMGI 128.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Electronic Gaming & Multimedia value chain with $81.9M market capitalization and -0.8% operating margin.
OpEx & R&D Reinvestment57.6% of Rev ($103M)
90D Engineering Disclosures0 Published
Investor FAQ ABUS vs GMGI Key Questions & Quantitative Answers
As of Nov 20, 2026, Arbutus Biopharma Corporation (ABUS) is the stronger overall head-to-head candidate over Golden Matrix Group, Inc. (GMGI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABUS carries a Unified Composite Score of 43.4/100 (HOLD) at $4.02 (10.2x Forward P/E, 80.1% operating margin), whereas GMGI carries 51.1/100 (HOLD) at $0.64 (128.2x Forward P/E, -0.8% operating margin). Composite vs. Pillar Nuance: While GMGI currently prints a higher short-term Unified Composite Score (51.1/100 HOLD vs. ABUS 43.4/100 HOLD), ABUS captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (80.1% vs. -0.8% operating margin) and revenue trajectory (-43.5% vs. +15.4% YoY).
ABUS leads the Growth & Scale pillar: ABUS posts -43.5% YoY revenue growth and +0.0% YoY earnings growth on $181M TTM revenue (91.9% gross margin, 80.1% operating margin), compared with GMGI at +15.4% YoY revenue growth and -99.6% YoY earnings growth on $179M TTM revenue (56.8% gross margin, -0.8% operating margin). On trailing 12-month operating scale, ABUS generates $181M in USD-normalized revenue versus $179M for GMGI. In operating R&D and SG&A reinvestment, ABUS deploys 11.8% of Rev ($21M) (0 90-day corporate R&D disclosures) versus 57.6% of Rev ($103M) (0 disclosures) for GMGI.
ABUS screens cheaper on headline valuation multiples. ABUS trades at 10.2x Forward P/E, 3.6x Trailing P/E, N/M PEG, and 2.0x EV/Revenue (unreported FCF margin), whereas GMGI trades at 128.2x Forward P/E, 128.2x Trailing P/E, N/M PEG, and 0.5x EV/Revenue (6.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABUS (269.6% ROE) versus GMGI (-5.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABUS carries 133.2% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.04β · 48% Vol realized risk). By comparison, GMGI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.40β · 117% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.